↓ Skip to main content

CMAB009 plus irinotecan versus irinotecan‐only as second‐line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild‐type metastatic colorectal cancer patients: promising findings from…

Overview of attention for article published in Cancer Communications, May 2019
Altmetric Badge

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
30 Mendeley